The study describes the synthesis of new compounds based on prior iNOS inhibitors, their potency and selectivity of action, and the evaluation of the most interesting compounds in different <i>in vitro</i> and <i>ex vivo</i> cell models of psoriasis. Here, NOS2 is linked to psoriasis.